Cheaper Versions of the Most Expensive Drugs May be Coming, but Monopolies Will Likely Remain

In May, the Food and Drug Administration issued much-anticipated guidance that could revolutionize the pricing of some of the most expensive drugs on the market in the U.S. and, possibly, globally.